Crossmark

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

Crossref DOI link: https://doi.org/10.1038/gim.2016.190

Published Print: 2017-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Kalia, Sarah S.

Adelman, Kathy

Bale, Sherri J.

Chung, Wendy K.

Eng, Christine

Evans, James P.

Herman, Gail E.

Hufnagel, Sophia B.

Klein, Teri E.

Korf, Bruce R.

McKelvey, Kent D.

Ormond, Kelly E.

Richards, C. Sue

Vlangos, Christopher N.

Watson, Michael

Martin, Christa L.

Miller, David T.
License Information

Text and Data Mining valid from 2017-02-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/gim.2016.190

Content Type: article

Copyright: © 2017, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics

Updates are available Erratum dated 2017-04-01

Click to view Erratum: https://doi.org/10.1038/gim.2017.17